Beyond Air, Inc.
NASDAQ:XAIR
0.36 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Beyond Air, Inc. |
Symbool | XAIR |
Munteenheid | USD |
Prijs | 0.359 |
Beurswaarde | 25,908,130 |
Dividendpercentage | 0% |
52-weken bereik | 0.296 - 2.17 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Steven Adam Lisi |
Website | https://www.beyondair.net |
An error occurred while fetching data.
Over Beyond Air, Inc.
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)